Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Clin Psychopharmacol ; 31(1): 4-9, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21192135

RESUMO

The primary aim of the present study was to investigate the relationship between steady state serum and cerebrospinal fluid (CSF) concentrations of olanzapine (OLA) and its metabolite 4'-N-desmethylolanzapine (DMO) in patients with schizophrenia or schizoaffective disorder treated with oral OLA as the only antipsychotic drug. The influence of smoking, gender, age, as well as polymorphisms in cytochrome P450 CYP2D6, CYP1A2, and ABCB1 genes on the serum and CSF drug levels was also analyzed. Thirty-seven white outpatients (10 smokers and 27 nonsmokers) were included. From 29 of them, CSF was collected successfully. A strong correlation (Spearman rank correlation [rs] = 0.93; P < 0.05) was found between serum and CSF concentrations of OLA and a somewhat weaker correlation (rs = 0.5; P < 0.05) between those of DMO. The CSF concentrations of OLA and DMO were on average 12% and 16% of those in serum. Extensive metabolizers of CYP2D6 had higher (P < 0.05) daily doses than poor metabolizers when the influence of smoking was taken into account. Smokers had lower (P < 0.01) concentration-to-dose ratios of OLA in serum (mean, 2.23 ng/mL per mg vs 3.32 ng/mL per mg) and CSF (0.27 ng/mL per mg vs 0.41 ng/mL per mg) than nonsmokers. The concentration-to-dose ratio for serum DMO decreased with increasing age (rs = -0.41; P < 0.05). Carriers of ABCB1 1236T/2677T/3435T haplotype had higher serum (mean, 37.7 ng/mL vs 22.5 ng/mL; P = 0.035) and CSF (4.7 ng/mL vs 2.6 ng/mL; P = 0.018) OLA concentrations than patients without this haplotype. The present study shows a strong correlation between serum and CSF concentrations of OLA, indicating that concentrations of OLA in serum reflect those in CSF.


Assuntos
Benzodiazepinas/sangue , Benzodiazepinas/líquido cefalorraquidiano , Transtornos Psicóticos/sangue , Transtornos Psicóticos/líquido cefalorraquidiano , Esquizofrenia/sangue , Esquizofrenia/líquido cefalorraquidiano , Subfamília B de Transportador de Cassetes de Ligação de ATP , Membro 1 da Subfamília B de Cassetes de Ligação de ATP/genética , Administração Oral , Adulto , Antipsicóticos/administração & dosagem , Antipsicóticos/sangue , Antipsicóticos/líquido cefalorraquidiano , Benzodiazepinas/administração & dosagem , Biomarcadores/sangue , Biomarcadores/líquido cefalorraquidiano , Citocromo P-450 CYP1A2/genética , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Olanzapina , Polimorfismo Genético/genética , Transtornos Psicóticos/tratamento farmacológico , Esquizofrenia/tratamento farmacológico , Adulto Jovem
2.
J Psychiatr Res ; 40(5): 454-9, 2006 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16081105

RESUMO

Previous reports on compounds in the cerebrospinal fluid (CSF) of pathological gamblers have focused on disturbed NA, DA and 5-HT function in the central nervous system. We have analysed precursors, transmitters and transmitter metabolites in 3 x 6 ml of CSF obtained from one female and 11 male pathological gamblers and 11 healthy male controls lumbar punctured at the L4-5 level after 8 h of fasting without preceding strict bedrest. Pathological gamblers displayed lower CSF levels of tryptophan and 5-HT while the opposite was the case for 5-HIAA, tyrosine, DA, HVA, DOPAC and HMPG. In contrast to previous studies, the NA level did not differ between pathological gamblers and healthy controls. A disrupted CSF gradient was noted for tryptophan, 5-HT, DA, HVA, DOPAC, NA and HMPG, but only in pathological gamblers. A disrupted gradient was found for 5-HIAA in both pathological gamblers and healthy controls. The results are in line with the presence of altered indoleamine and catecholamine function in pathological gamblers as well as an altered CSF transport from the brain to the lumbar compartment in such gamblers.


Assuntos
Monoaminas Biogênicas/líquido cefalorraquidiano , Transtornos Disruptivos, de Controle do Impulso e da Conduta/líquido cefalorraquidiano , Jogo de Azar , Adulto , Alcoolismo/líquido cefalorraquidiano , Feminino , Humanos , Masculino , Transtornos do Humor/líquido cefalorraquidiano , Valores de Referência , Serotonina/líquido cefalorraquidiano , Fumar/líquido cefalorraquidiano , Triptofano/líquido cefalorraquidiano
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA